Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06713239

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Led by Cleerly, Inc. · Updated on 2026-03-18

1000

Participants Needed

21

Research Sites

93 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

PARAMOUNT is a prospective randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with suspicion of coronary artery disease (CAD), using a CT-based coronary atherosclerotic plaque assessment by AI-enabled quantitative software improves: certainty for diagnosis of CAD, control of CAD risk factors and efficiency of ICA referral with appropriate PCI compared to the usual care strategy based on current AHA/ACC guidelines for care of symptomatic patients with suspicion of CAD.

CONDITIONS

Official Title

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Older than 18 years
  • Symptomatic patients suspected of having coronary artery disease, including those referred for elective, non-urgent diagnostic testing such as stress tests
Not Eligible

You will not qualify if you...

  • LDL cholesterol level less than 100 mg/dL
  • Currently or previously treated beyond primary prevention guidelines
  • Suspected acute coronary syndrome or unstable clinical status
  • Planned cardiovascular procedures like coronary angiography, cardiac surgery, or non-coronary vascular procedures
  • Noninvasive or invasive cardiovascular testing for coronary artery disease within the past year
  • Known history of obstructive coronary artery disease (prior myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, or stenosis 50% or greater)
  • Known ejection fraction 40% or less or other moderate to severe valvular or congenital heart disease
  • Contraindications to coronary CT angiography

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 21 locations

1

Cardiology Associates of Mobile

Mobile, Alabama, United States, 36608

Actively Recruiting

2

Valiance Clinical Research- Huntington Park

Huntington Park, California, United States, 90255

Actively Recruiting

3

Cardiovascular Institute of San Diego

San Diego, California, United States, 91911

Actively Recruiting

4

Valiance Clinical Research- Tarzana

Tarzana, California, United States, 91356

Actively Recruiting

5

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Torrance, California, United States, 90502

Actively Recruiting

6

Intermountain Health Saint Joseph Hospital

Broomfield, Colorado, United States, 80021

Actively Recruiting

7

Tampa Cardiovascular Interventions and Research

Tampa, Florida, United States, 33614

Actively Recruiting

8

Flourish Research

Winter Park, Florida, United States, 32789

Actively Recruiting

9

Endeavor Health Clinical Operations

Evanston, Illinois, United States, 60201

Actively Recruiting

10

MercyOne Des Moines Medical Center

West Des Moines, Iowa, United States, 50266

Actively Recruiting

11

Saint Elizabeth Medical Center

Edgewood, Kentucky, United States, 41017

Actively Recruiting

12

Tulane University

New Orleans, Louisiana, United States, 70112

Actively Recruiting

13

Flourish- Bowie

Bowie, Maryland, United States, 20715

Actively Recruiting

14

St. Louis Heart and Vascular

Bridgeton, Missouri, United States, 63044

Actively Recruiting

15

Advanced Heart and Vascular Institute of Hunterdon

Flemington, New Jersey, United States, 08822

Actively Recruiting

16

Capital Cardiology Associates

Albany, New York, United States, 12211

Actively Recruiting

17

University of Cincinnatti

Cincinnati, Ohio, United States, 45221

Actively Recruiting

18

Oklahoma Cardiovascular Research Group

Oklahoma City, Oklahoma, United States, 73120

Actively Recruiting

19

The University of Tennessee Medical Center

Knoxville, Tennessee, United States, 37920

Actively Recruiting

20

Medical City Fort Worth Hospital

Fort Worth, Texas, United States, 76104

Actively Recruiting

21

Chippenham and Johnston Willis Hospitals

Richmond, Virginia, United States, 23225

Actively Recruiting

Loading map...

Research Team

R

Ryann Sardinia

CONTACT

V

Vidhya Kumar

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here